Bristol-Myers Squibb Common Stock

Bristol-Myers Squibb (BMY) currently reports a common stock of $290M as of June 2026. In the prior-year period, the figure was $0. Use the charts on this page to explore Bristol-Myers Squibb's common stock history and peer comparisons.

Bristol-Myers Squibb's common stock changed from $0 to $290M (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Bristol-Myers Squibb reported $290M in common stock as of June 2026. In the prior-year period, the figure was $0. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current common stock of $290M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Bristol-Myers Squibb, and consider following BMY for alerts when major investors trade the stock.

Bristol-Myers Squibb is classified in the Healthcare sector. On common stock, it currently shows $290M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing BMY with unrelated industries.